chr1-32180413-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000373610.8(TXLNA):c.68C>T(p.Pro23Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000843 in 1,613,918 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000373610.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TXLNA | NM_175852.4 | c.68C>T | p.Pro23Leu | missense_variant | 2/11 | ENST00000373610.8 | NP_787048.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TXLNA | ENST00000373610.8 | c.68C>T | p.Pro23Leu | missense_variant | 2/11 | 1 | NM_175852.4 | ENSP00000362712 | P1 | |
TXLNA | ENST00000373609.1 | c.68C>T | p.Pro23Leu | missense_variant | 1/10 | 1 | ENSP00000362711 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152258Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250418Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135540
GnomAD4 exome AF: 0.0000883 AC: 129AN: 1461660Hom.: 0 Cov.: 30 AF XY: 0.0000853 AC XY: 62AN XY: 727116
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74394
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 04, 2022 | The c.68C>T (p.P23L) alteration is located in exon 2 (coding exon 1) of the TXLNA gene. This alteration results from a C to T substitution at nucleotide position 68, causing the proline (P) at amino acid position 23 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at